Actin-Binding rho Activating Protein (ABRA) (Middle Region) Peptid
ABRA
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN972767
Kurzübersicht für Actin-Binding rho Activating Protein (ABRA) (Middle Region) Peptid (ABIN972767)
Target
ABRA
(Actin-Binding rho Activating Protein (ABRA))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Sequenz
- QWADEHIQSQ KLNPFSEEFD YELAMSTRLH KGDEGYGRPK EGTKTAERAK
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-ABRA Antibody(ARP52674_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- ABRA (Actin-Binding rho Activating Protein (ABRA))
-
Hintergrund
-
ABRA acts as an activator of serum response factor (SRF)-dependent transcription possibly by inducing nuclear translocation of MKL1 or MKL2 and through a mechanism requiring Rho-actin signaling.
Alias Symbols: STARS
Protein Interaction Partner: ACTB,ACTC1
Protein Size: 381 -
Molekulargewicht
- 43 kDa
-
Gen-ID
- 137735
-
NCBI Accession
- NM_139166, NP_631905
-
UniProt
- Q8N0Z2
Target
-
Sie sind hier:
